Produção Nacional
Revisado por pares
Accelerated partial breast irradiation: Current status with a focus on clinical practice
2018; Wiley; Volume: 25; Issue: 1 Linguagem: Inglês
10.1111/tbj.13164
ISSN1524-4741
AutoresFabiana Accioli Miranda, Lorine Arias Bonifácio Teixeira, Rebeca Neves Heinzen, Felipe Andrade, Tarek Hijal, Thomas A. Buchholz, Fábio Ynoe de Moraes, Philip Poortmans, Gustavo Nader Marta,
Tópico(s)Cancer Genomics and Diagnostics
ResumoThe Breast JournalVolume 25, Issue 1 p. 124-128 SHORT COMMUNICATION Accelerated partial breast irradiation: Current status with a focus on clinical practice Fabiana A. Miranda MD, Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, BrazilSearch for more papers by this authorLorine A. B. Teixeira MD, Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, Brazil Department of Radiology and Oncology of University of São Paulo, Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP/FMUSP), São Paulo, BrazilSearch for more papers by this authorRebeca N. Heinzen MD, Department of Breast Surgery, Hospital Sírio-Libanês, São Paulo, BrazilSearch for more papers by this authorFelipe Eduardo M. de Andrade MD, Department of Breast Surgery, Hospital Sírio-Libanês, São Paulo, BrazilSearch for more papers by this authorTarek Hijal MD, Division of Radiation Oncology, McGill University Health Centre, Montréal, Quebec, CanadaSearch for more papers by this authorThomas A. Buchholz MD, PhD, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TexasSearch for more papers by this authorFabio Y. Moraes MD, Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, Brazil Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, CanadaSearch for more papers by this authorPhilip Poortmans MD, PhD, Department of Radiation Oncology, Institut Curie, Paris, FranceSearch for more papers by this authorGustavo N. Marta MD, PhD, Corresponding Author gustavo.marta@hc.fm.usp.br orcid.org/0000-0002-3298-3684 Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, Brazil Department of Radiology and Oncology of University of São Paulo, Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP/FMUSP), São Paulo, Brazil Correspondence Gustavo Nader Marta, MD, PhD, Department of Radiation Oncology, Hospital Sírio–Libanês, Sao Paulo, Brazil. Email: gustavo.marta@hc.fm.usp.brSearch for more papers by this author Fabiana A. Miranda MD, Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, BrazilSearch for more papers by this authorLorine A. B. Teixeira MD, Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, Brazil Department of Radiology and Oncology of University of São Paulo, Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP/FMUSP), São Paulo, BrazilSearch for more papers by this authorRebeca N. Heinzen MD, Department of Breast Surgery, Hospital Sírio-Libanês, São Paulo, BrazilSearch for more papers by this authorFelipe Eduardo M. de Andrade MD, Department of Breast Surgery, Hospital Sírio-Libanês, São Paulo, BrazilSearch for more papers by this authorTarek Hijal MD, Division of Radiation Oncology, McGill University Health Centre, Montréal, Quebec, CanadaSearch for more papers by this authorThomas A. Buchholz MD, PhD, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TexasSearch for more papers by this authorFabio Y. Moraes MD, Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, Brazil Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, CanadaSearch for more papers by this authorPhilip Poortmans MD, PhD, Department of Radiation Oncology, Institut Curie, Paris, FranceSearch for more papers by this authorGustavo N. Marta MD, PhD, Corresponding Author gustavo.marta@hc.fm.usp.br orcid.org/0000-0002-3298-3684 Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, Brazil Department of Radiology and Oncology of University of São Paulo, Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP/FMUSP), São Paulo, Brazil Correspondence Gustavo Nader Marta, MD, PhD, Department of Radiation Oncology, Hospital Sírio–Libanês, Sao Paulo, Brazil. Email: gustavo.marta@hc.fm.usp.brSearch for more papers by this author First published: 07 December 2018 https://doi.org/10.1111/tbj.13164Citations: 6 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinked InRedditWechat Abstract Accelerated partial breast irradiation (APBI), a radiation technique in which only the tumor bed is treated, has now become an acceptable radiation modality for selected early-stage breast cancer patients. Compared to conventional whole breast irradiation (WBI), APBI has some benefits with regard to the reduced total irradiated breast volume and the shorter treatment time. The role of APBI, which can be delivered using diverse techniques, has been evaluated in several prospective randomized phase III trials. These clinical trials demonstrate diverging outcomes relating to local recurrence, while establishing comparable effect in terms of survival between APBI with WBI. The aim of this study was to review the current status of APBI with a focus on clinical practice. Citing Literature Volume25, Issue1January/February 2019Pages 124-128 RelatedInformation
Referência(s)